Evidence map›Paper›PMID 26196440›Full record

ArticleTranslational psychiatry2015

Analysis of exome sequence in 604 trios for recessive genotypes in schizophrenia.

E Rees, G Kirov, J T Walters, A L Richards, D Howrigan, D H Kavanagh, A J Pocklington, M Fromer, D M Ruderfer, L Georgieva and 28 more

Open access · goldAbstract read
In one paragraph

Article in Translational psychiatry, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 24 papers.

0numbers the graph read from it
0cells of the map it votes in
24citing papers in PubMed
4.7field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

24 citing papers in PubMed, 41 citations in OpenAlex.

  1. Article
  2. Article
  3. Genes · 2024
    Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Schizophrenia and Hereditary Polyneuropathy:Frontiers in psychiatry · 2019
    Article
  14. Rare compound heterozygous missenseNeuropsychiatric disease and treatment · 2019
    Article
  15. Article
  16. Article
  17. Recent Advances in the Genetics of Schizophrenia.Molecular neuropsychiatry · 2018
    Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

38 authors at 11 institutions in 5 countries.

E ReesMedical Research Council Centre for Neuropsychiatric Genetics and Genomics, Institute of Psychological Medicine and Clinical Neurosciences, Cardiff University, Cardiff, UK.
G KirovMedical Research Council Centre for Neuropsychiatric Genetics and Genomics, Institute of Psychological Medicine and Clinical Neurosciences, Cardiff University, Cardiff, UK.
J T WaltersMedical Research Council Centre for Neuropsychiatric Genetics and Genomics, Institute of Psychological Medicine and Clinical Neurosciences, Cardiff University, Cardiff, UK.
A L RichardsMedical Research Council Centre for Neuropsychiatric Genetics and Genomics, Institute of Psychological Medicine and Clinical Neurosciences, Cardiff University, Cardiff, UK.
D HowriganAnalytic and Translational Genetics Unit, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
D H KavanaghDivision of Psychiatric Genomics, Department of Psychiatry, Institute for Genomics and Multiscale Biology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
A J PocklingtonMedical Research Council Centre for Neuropsychiatric Genetics and Genomics, Institute of Psychological Medicine and Clinical Neurosciences, Cardiff University, Cardiff, UK.
M Fromer1] Division of Psychiatric Genomics, Department of Psychiatry, Institute for Genomics and Multiscale Biology, Icahn School of Medicine at Mount Sinai, New York, NY, USA [2] Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
D M RuderferDivision of Psychiatric Genomics, Department of Psychiatry, Institute for Genomics and Multiscale Biology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
L GeorgievaMedical Research Council Centre for Neuropsychiatric Genetics and Genomics, Institute of Psychological Medicine and Clinical Neurosciences, Cardiff University, Cardiff, UK.
N CarreraMedical Research Council Centre for Neuropsychiatric Genetics and Genomics, Institute of Psychological Medicine and Clinical Neurosciences, Cardiff University, Cardiff, UK.
P GormleyProgram in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
P PaltaInstitute for Molecular Medicine Finland, University of Helsinki, Helsinki, Finland.ORCID 0000000193207008
H WilliamsGOSgene,ICH Genetics and Genomic Medicine Program, Institute of Child Health, Faculty of Population Health Sciences, University College London, London, UK.
S DwyerMolecular Genetics and Genomics, National Heart and Lung Institute, Imperial College London, London, UK.
J S JohnsonDivision of Psychiatric Genomics, Department of Psychiatry, Institute for Genomics and Multiscale Biology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
P RoussosDivision of Psychiatric Genomics, Department of Psychiatry, Institute for Genomics and Multiscale Biology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
D D BarkerStanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
E BanksProgram in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
V MilanovaDepartment of Psychiatry, Medical University, Sofia, Bulgaria.
S A RoseDivision of Psychiatric Genomics, Department of Psychiatry, Institute for Genomics and Multiscale Biology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
K ChambertStanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
M MahajanDivision of Psychiatric Genomics, Department of Psychiatry, Institute for Genomics and Multiscale Biology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
E M ScolnickStanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
J L MoranStanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
M T Tsuang1] Center for Behavioral Genomics and Institute for Genomic Medicine, University of California, San Diego, La Jolla, CA, USA [2] Department of Psychiatry, University of California, San Diego, La Jolla, CA, USA [3] Harvard Institute of Psychiatric Epidemiology and Genetics, Boston, MA, USA.
S J GlattPsychiatric Genetic Epidemiology and Neurobiology Laboratory (PsychGENe Lab); Department of Psychiatry and Behavioral Sciences, SUNY Upstate Medical University, Syracuse, NY, USA.
W J ChenInstitute of Epidemiology and Preventive Medicine, College of Public Health, National Taiwan University, Taipei, Taiwan.
H-G Hwu1] Institute of Epidemiology and Preventive Medicine, College of Public Health, National Taiwan University, Taipei, Taiwan [2] Department of Psychiatry, National Taiwan University Hospital, College of Medicine, National Taiwan University, Taipei, Taiwan.
Taiwanese Trios Exome Sequencing Consortium
B M Neale1] Analytic and Translational Genetics Unit, Department of Medicine, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA [2] Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
A PalotieProgram in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
P SklarDivision of Psychiatric Genomics, Department of Psychiatry, Institute for Genomics and Multiscale Biology, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
S M Purcell1] Division of Psychiatric Genomics, Department of Psychiatry, Institute for Genomics and Multiscale Biology, Icahn School of Medicine at Mount Sinai, New York, NY, USA [2] Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, MA, USA.
S A McCarroll1] Stanley Center for Psychiatric Research, Broad Institute of MIT and Harvard, Cambridge, MA, USA [2] Program in Medical and Population Genetics, Broad Institute of MIT and Harvard, Cambridge, MA, USA [3] Department of Genetics, Harvard Medical School, Boston, MA, USA.
P HolmansMedical Research Council Centre for Neuropsychiatric Genetics and Genomics, Institute of Psychological Medicine and Clinical Neurosciences, Cardiff University, Cardiff, UK.
M J OwenMedical Research Council Centre for Neuropsychiatric Genetics and Genomics, Neuroscience and Mental Health Research Institute, Institute of Psychological Medicine and Clinical Neurosciences, Cardiff University, Cardiff, UK.
M C O'DonovanMedical Research Council Centre for Neuropsychiatric Genetics and Genomics, Institute of Psychological Medicine and Clinical Neurosciences, Cardiff University, Cardiff, UK.
Broad Institute · USCardiff University · GBIcahn School of Medicine at Mount Sinai · USNational Taiwan University · TWGenomics (United Kingdom) · GBHarvard University · USMedical University of Sofia · BGSUNY Upstate Medical University · USUniversity College London · GBUniversity of California San Diego · USUniversity of Helsinki · FI

Funding

Large Scale Sequencing and Analysis of GenomesU54HG003067 · NHGRI · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI GABRIEL, STACEY, LANDER, ERIC S · 2004 to 2015
$568.6M
1/2 Expanding Rapid Ascertainment Networks Of Schizophrenia Families In TaiwanR01MH085560 · NIMH · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI TSUANG, MING T. · 2008 to 2012
$5.8M
Haplotype Mapping of Chromosome 5 Schizophrenia LocusR01MH071681 · NIMH · MASSACHUSETTS INSTITUTE OF TECHNOLOGY · PI PURCELL, SHAUN M · 2006 to 2010
$2.6M
Software for the analysis of large-scale genotyping and sequencing studiesR01HG005827 · NHGRI · MASSACHUSETTS GENERAL HOSPITAL · PI PURCELL, SHAUN M · 2010 to 2016
$2.1M
2/2-Expanding Rapid Ascertainment Networks Of Schizophrenia Families In TaiwanR01MH085521 · NIMH · UPSTATE MEDICAL UNIVERSITY · PI GLATT, STEPHEN J · 2008 to 2012
$1.5M
Leveraging identity-by-descent information in large-scale population sequencingR01MH099126 · NIMH · ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI · PI PURCELL, SHAUN M · 2012 to 2014
$1.0M
Medical Research Council G0800509Medical Research Council G0801418Medical Research Council MR/L010305/1NHGRI NIH HHS R01 HG005827NHGRI NIH HHS R01HG005827NHGRI NIH HHS U54 HG003067NHGRI NIH HHS U54HG003067NIMH NIH HHS R01 MH071681NIMH NIH HHS R01MH071681NIMH NIH HHS R01 MH085521NIMH NIH HHS R01 MH085560NIMH NIH HHS R01MH085560NIMH NIH HHS R01 MH099126NIMH NIH HHS R01MH099126Wellcome Trust WT089062Wellcome Trust WT098051
6 · The paper itself

Abstract

Genetic associations involving both rare and common alleles have been reported for schizophrenia but there have been no systematic scans for rare recessive genotypes using fully phased trio data. Here, we use exome sequencing in 604 schizophrenia proband-parent trios to investigate the role of recessive (homozygous or compound heterozygous) nonsynonymous genotypes in the disorder. The burden of recessive genotypes was not significantly increased in probands at either a genome-wide level or in any individual gene after adjustment for multiple testing. At a system level, probands had an excess of nonsynonymous compound heterozygous genotypes (minor allele frequency, MAF ⩽ 1%) in voltage-gated sodium channels (VGSCs; eight in probands and none in parents, P = 1.5 × 10(-)(4)). Previous findings of multiple de novo loss-of-function mutations in this gene family, particularly SCN2A, in autism and intellectual disability provide biological and genetic plausibility for this finding. Pointing further to the involvement of VGSCs in schizophrenia, we found that these genes were enriched for nonsynonymous mutations (MAF ⩽ 0.1%) in cases genotyped using an exome array, (5585 schizophrenia cases and 8103 controls), and that in the trios data, synaptic proteins interacting with VGSCs were also enriched for both compound heterozygosity (P = 0.018) and de novo mutations (P = 0.04). However, we were unable to replicate the specific association with compound heterozygosity at VGSCs in an independent sample of Taiwanese schizophrenia trios (N = 614). We conclude that recessive genotypes do not appear to make a substantial contribution to schizophrenia at a genome-wide level. Although multiple lines of evidence, including several from this study, suggest that rare mutations in VGSCs contribute to the disorder, in the absence of replication of the original findings regarding compound heterozygosity, this conclusion requires evaluation in a larger sample of trios.

Indexed as

Case-Control StudiesExomeFamilyFemaleGene FrequencyGenes, RecessiveGenetic Predisposition to DiseaseGenotypeHeterozygoteHomozygoteHumansMaleSchizophreniaVoltage-Gated Sodium ChannelsVoltage-Gated Sodium Channels

Identifiers

PMID26196440
PMCPMC5068730
OpenAlexW2119445591

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.